Cincinnati Children's Launches Advanced Leukemia Therapies and Research Center
CINCINNATI, Sept. 26, 2023 /PRNewswire/ -- Cincinnati Children's, the top ranked pediatric hospital and top ranked cancer program in the country by U.S. News & World Report, continues to break new ground with the launch of the first of its kind Advanced Leukemia Therapies and Research Center. The center will integrate the expertise of the world class research and clinical programs at Cincinnati Children's and increase patient access to cutting edge clinical trials.
- "We want to improve the outcomes of Acute Myeloid Leukemia (AML) patients by spearheading innovative and transformative research that will bring new treatment options to blood cancer patients of any age," said Daniel Starczynowski, PhD, director of the Cincinnati Children's Advanced Leukemia Therapies and Research Center, associate director of the Cancer and Blood Diseases Institute and associate director for basic science research at the University of Cincinnati Cancer Center.
- Cincinnati Children's formed the Advanced Leukemia Therapies and Research Center to accelerate more scientific discoveries like this to bring more curative options to AML patients.
- The addition of the Advanced Leukemia Therapies and Research Center further confirms Cincinnati Children's as a global leader in cancer care, research and education.
- "The Advanced Leukemia Therapies and Research Center and the progress we are making there sets Cincinnati Children's apart from other pediatric academic research centers."